Chengdu Easton Biopharmaceuticals (688513.SH): Ailamode tablets obtain drug registration certificate.
Yuandong Bio (688513.SH) announces the issuance of the drug registration certificate for Elamod tablets, a wholly-owned subsidiary of the company...
Chengdu Easton Biopharmaceuticals (688513.SH) announced that its subsidiary, Chengdu Shuode Pharmaceuticals Co., Ltd. (referred to as "Shuode Pharmaceuticals"), has recently received the Drug Registration Certificate issued by the National Medical Products Administration (referred to as "NMPA") for the drug "Elamod Tablets".
Elamod Tablets contain the active ingredient Elamod and are indicated for active rheumatoid arthritis. Elamod Tablets are classified as a Class B variety in the "National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance Drug Catalogue (2024)".
Related Articles
Tianfeng: "Artificial intelligence +" action accelerates the landing of "AI+ applications". It is recommended to pay attention to XD INC (02400)."
Guojin Hwen Ask Non-ferrous Metals: Supply Contraction and AI Demand Resonance, Non-ferrous Sector "CommodityStock" Value Transmission in Progress.
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
Tianfeng: "Artificial intelligence +" action accelerates the landing of "AI+ applications". It is recommended to pay attention to XD INC (02400)."
Guojin Hwen Ask Non-ferrous Metals: Supply Contraction and AI Demand Resonance, Non-ferrous Sector "CommodityStock" Value Transmission in Progress.
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
RECOMMEND
